Literature DB >> 2407295

Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi.

J J Cazzulo1, M C Cazzulo Franke, J Martínez, B M Franke de Cazzulo.   

Abstract

A cysteine proteinase, purified to homogeneity from epimastigotes of Trypanosoma cruzi, was strongly inhibited by L-trans-epoxysuccinylleucylamido(4-guanidino)butane (E-64). The second-order rate constant was 20,800 M-1.s-1, and the reagent could be used for active site titration. The enzyme hydrolysed chromogenic peptides at the carboxyl Arg or Lys; it required at least one more amino acid, preferably Arg, Phe, Val or Leu, between the terminal Arg or Lys and the amino-blocking group. Enzyme activity on azocasein at pH 5.0 was increased by urea, maximal activity being attained at 2 M, and was still as active at 5 M urea as in its absence. Guanidine hydrochloride and KSCN also activated at low concentrations, but caused a strong inhibition above 2 M and 1 M, respectively. When azocasein was tested as a substrate at pH 7.0, there was no activation, and when synthetic substrates were used all chaotropic agents tested were inhibitory. The results suggest that the enzyme, for which we propose the trivial name 'cruzipain', differs in some aspects from all other cysteine proteinases described so far, although it shares several of the properties of mammalian cathepsin L.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407295     DOI: 10.1016/0167-4838(90)90166-d

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

Authors:  J M Santana; P Grellier; J Schrével; A R Teixeira
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.

Authors:  Daniel J Rigden; Vladimir V Mosolov; Michael Y Galperin
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

3.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

4.  Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.

Authors:  Andrea Pellegrini; Eugenio Antonio Carrera-Silva; Alfredo Arocena; Roxana Carolina Cano; Maria Pilar Aoki; Susana Gea
Journal:  Med Microbiol Immunol       Date:  2011-03-24       Impact factor: 3.402

5.  The interplay between folding-facilitating mechanisms in Trypanosoma cruzi endoplasmic reticulum.

Authors:  Ianina Conte; Carlos Labriola; Juan J Cazzulo; Roberto Docampo; Armando J Parodi
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

6.  Review on Trypanosoma cruzi: Host Cell Interaction.

Authors:  Wanderley de Souza; Tecia Maria Ulisses de Carvalho; Emile Santos Barrias
Journal:  Int J Cell Biol       Date:  2010-07-29

7.  All Trypanosoma cruzi developmental forms present lysosome-related organelles.

Authors:  Celso Sant'Anna; Fabiola Parussini; Daniela Lourenço; Wanderley de Souza; Juan Jose Cazzulo; Narcisa Leal Cunha-e-Silva
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

Review 8.  Intermediate metabolism in Trypanosoma cruzi.

Authors:  J J Cazzulo
Journal:  J Bioenerg Biomembr       Date:  1994-04       Impact factor: 2.945

9.  Major cysteine protease (cruzipain) in Z3 sylvatic isolates of Trypanosoma cruzi from Rio de Janeiro, Brazil.

Authors:  S A O Gomes; D Misael; B A Silva; D Feder; C S Silva; T C M Gonçalves; A L S Santos; J R Santos-Mallet
Journal:  Parasitol Res       Date:  2009-05-13       Impact factor: 2.289

10.  Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Trypanosoma cruzi and Inhibit Both Aspartyl-Type Peptidase and Cruzipain Activities Detected in These Crucial Organelles.

Authors:  Leandro S Sangenito; Miria G Pereira; Thais Souto-Padron; Marta H Branquinha; André L S Santos
Journal:  Trop Med Infect Dis       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.